⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Knight Terapeutics and Eurofarma eye Biotoscana -source

Published 2019-10-07, 10:38 a/m
© Reuters.  Knight Terapeutics and Eurofarma eye Biotoscana -source
GUD
-
GBIO33
-

SAO PAULO, Oct 7 (Reuters) - Canada's Knight Terapeutics GUD.TO and Brazilian pharmaceuticals company Eurofarma are interested in acquiring control of Brazilian pharmaceutical company Biotoscana Investments SA GBIO33.SA , one source with knowledge of the matter said.

Financial blog Brazil Journal reported the deal earlier on Monday, citing unnamed sources.

Biotoscana's largest shareholders, private equity firm Advent International and specialist investment firm EW Healthcare Partners, which hold 27% and 17% of the company, respectively, are in talks to sell their stakes, Brazil Journal said.

Shares in Biotoscana were up 11.3% in early morning trading to 9 reais. Biotoscana's bylaws mandate an offer to all shareholders if the company's control changes.

Advent, EW Healthcare, Eurofarma, Knight Terapeutics and Biotoscana did not reply immediately to requests for comment. ($1 = 4.0648 reais)

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.